Global Ibuprofen API Market 2023-2027

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global ibuprofen API market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global ibuprofen API market 2017 - 2021 ($ million)
4.2 End user Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End user Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Pharmaceutical companies - Market size and forecast 2022-2027
Exhibit 34: Chart on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
6.4 Contract manufacturing organizations - Market size and forecast 2022-2027
Exhibit 38: Chart on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by End-user
Exhibit 42: Market opportunity by End-user ($ million)
Exhibit 43: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product
7.1 Market segments
Exhibit 44: Chart on Product - Market share 2022-2027 (%)
Exhibit 45: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 Prescription - Market size and forecast 2022-2027
Exhibit 48: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Prescription - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
7.4 Over-the-counter - Market size and forecast 2022-2027
Exhibit 52: Chart on Over-the-counter - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Over-the-counter - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Over-the-counter - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Over-the-counter - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Product
Exhibit 56: Market opportunity by Product ($ million)
Exhibit 57: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share by geography 2022-2027 (%)
Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2022-2027
Exhibit 63: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.4 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 India - Market size and forecast 2022-2027
Exhibit 83: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on India - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 99: Market opportunity by geography ($ million)
Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Athos Chemicals Pvt. Ltd.
Exhibit 107: Athos Chemicals Pvt. Ltd. - Overview
Exhibit 108: Athos Chemicals Pvt. Ltd. - Product/Service
Exhibit 109: Athos Chemicals Pvt. Ltd. - Key offerings
12.4 Azelis SA
Exhibit 110: Azelis SA - Overview
Exhibit 111: Azelis SA - Product/Service
Exhibit 112: Azelis SA - Key offerings
12.5 BASF SE
Exhibit 113: BASF SE - Overview
Exhibit 114: BASF SE - Business segments
Exhibit 115: BASF SE - Key news
Exhibit 116: BASF SE - Key offerings
Exhibit 117: BASF SE - Segment focus
12.6 Chemino Pharma Ltd.
Exhibit 118: Chemino Pharma Ltd. - Overview
Exhibit 119: Chemino Pharma Ltd. - Product/Service
Exhibit 120: Chemino Pharma Ltd. - Key offerings
12.7 Dr Reddys Laboratories Ltd.
Exhibit 121: Dr Reddys Laboratories Ltd. - Overview
Exhibit 122: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 123: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 124: Dr Reddys Laboratories Ltd. - Segment focus
12.8 Granules India Ltd.
Exhibit 125: Granules India Ltd. - Overview
Exhibit 126: Granules India Ltd. - Product/Service
Exhibit 127: Granules India Ltd. - Key news
Exhibit 128: Granules India Ltd. - Key offerings
12.9 IOL Chemicals and Pharmaceuticals Ltd.
Exhibit 129: IOL Chemicals and Pharmaceuticals Ltd. - Overview
Exhibit 130: IOL Chemicals and Pharmaceuticals Ltd. - Business segments
Exhibit 131: IOL Chemicals and Pharmaceuticals Ltd. - Key offerings
Exhibit 132: IOL Chemicals and Pharmaceuticals Ltd. - Segment focus
12.10 Octavius Pharma Pvt Ltd.
Exhibit 133: Octavius Pharma Pvt Ltd. - Overview
Exhibit 134: Octavius Pharma Pvt Ltd. - Product/Service
Exhibit 135: Octavius Pharma Pvt Ltd. - Key offerings
12.11 Piramal Enterprises Ltd.
Exhibit 136: Piramal Enterprises Ltd. - Overview
Exhibit 137: Piramal Enterprises Ltd. - Business segments
Exhibit 138: Piramal Enterprises Ltd. - Key offerings
Exhibit 139: Piramal Enterprises Ltd. - Segment focus
12.12 Rochem International Inc.
Exhibit 140: Rochem International Inc. - Overview
Exhibit 141: Rochem International Inc. - Product/Service
Exhibit 142: Rochem International Inc. - Key offerings
12.13 SI Group Inc.
Exhibit 143: SI Group Inc. - Overview
Exhibit 144: SI Group Inc. - Product/Service
Exhibit 145: SI Group Inc. - Key offerings
12.14 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd.
Exhibit 146: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Overview
Exhibit 147: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Product/Service
Exhibit 148: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Key offerings
12.15 Solara Active Pharma Sciences Ltd.
Exhibit 149: Solara Active Pharma Sciences Ltd. - Overview
Exhibit 150: Solara Active Pharma Sciences Ltd. - Product/Service
Exhibit 151: Solara Active Pharma Sciences Ltd. - Key offerings
12.16 Strides Pharma Science Ltd.
Exhibit 152: Strides Pharma Science Ltd. - Overview
Exhibit 153: Strides Pharma Science Ltd. - Business segments
Exhibit 154: Strides Pharma Science Ltd. - Key offerings
Exhibit 155: Strides Pharma Science Ltd. - Segment focus
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 156: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 157: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 161: Inclusions checklist
Exhibit 162: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 163: Currency conversion rates for US$
13.4 Research methodology
Exhibit 164: Research methodology
Exhibit 165: Validation techniques employed for market sizing
Exhibit 166: Information sources
13.5 List of abbreviations
Exhibit 167: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global ibuprofen API market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - End user Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on End-user - Market share 2022-2027 (%)
Exhibits 31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Pharmaceutical companies - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Pharmaceutical companies - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Contract manufacturing organizations - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Contract manufacturing organizations - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by End-user ($ million)
Exhibits 43: Data Table on Market opportunity by End-user ($ million)
Exhibits 44: Chart on Product - Market share 2022-2027 (%)
Exhibits 45: Data Table on Product - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Product
Exhibits 47: Data Table on Comparison by Product
Exhibits 48: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Prescription - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Over-the-counter - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Over-the-counter - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Over-the-counter - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Over-the-counter - Year-over-year growth 2022-2027 (%)
Exhibits 56: Market opportunity by Product ($ million)
Exhibits 57: Data Table on Market opportunity by Product ($ million)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share by geography 2022-2027 (%)
Exhibits 60: Data Table on Market share by geography 2022-2027 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 99: Market opportunity by geography ($ million)
Exhibits 100: Data Tables on Market opportunity by geography ($ million)
Exhibits 101: Impact of drivers and challenges in 2022 and 2027
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Athos Chemicals Pvt. Ltd. - Overview
Exhibits 108: Athos Chemicals Pvt. Ltd. - Product/Service
Exhibits 109: Athos Chemicals Pvt. Ltd. - Key offerings
Exhibits 110: Azelis SA - Overview
Exhibits 111: Azelis SA - Product/Service
Exhibits 112: Azelis SA - Key offerings
Exhibits 113: BASF SE - Overview
Exhibits 114: BASF SE - Business segments
Exhibits 115: BASF SE - Key news
Exhibits 116: BASF SE - Key offerings
Exhibits 117: BASF SE - Segment focus
Exhibits 118: Chemino Pharma Ltd. - Overview
Exhibits 119: Chemino Pharma Ltd. - Product/Service
Exhibits 120: Chemino Pharma Ltd. - Key offerings
Exhibits 121: Dr Reddys Laboratories Ltd. - Overview
Exhibits 122: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 123: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 124: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 125: Granules India Ltd. - Overview
Exhibits 126: Granules India Ltd. - Product/Service
Exhibits 127: Granules India Ltd. - Key news
Exhibits 128: Granules India Ltd. - Key offerings
Exhibits 129: IOL Chemicals and Pharmaceuticals Ltd. - Overview
Exhibits 130: IOL Chemicals and Pharmaceuticals Ltd. - Business segments
Exhibits 131: IOL Chemicals and Pharmaceuticals Ltd. - Key offerings
Exhibits 132: IOL Chemicals and Pharmaceuticals Ltd. - Segment focus
Exhibits 133: Octavius Pharma Pvt Ltd. - Overview
Exhibits 134: Octavius Pharma Pvt Ltd. - Product/Service
Exhibits 135: Octavius Pharma Pvt Ltd. - Key offerings
Exhibits 136: Piramal Enterprises Ltd. - Overview
Exhibits 137: Piramal Enterprises Ltd. - Business segments
Exhibits 138: Piramal Enterprises Ltd. - Key offerings
Exhibits 139: Piramal Enterprises Ltd. - Segment focus
Exhibits 140: Rochem International Inc. - Overview
Exhibits 141: Rochem International Inc. - Product/Service
Exhibits 142: Rochem International Inc. - Key offerings
Exhibits 143: SI Group Inc. - Overview
Exhibits 144: SI Group Inc. - Product/Service
Exhibits 145: SI Group Inc. - Key offerings
Exhibits 146: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Overview
Exhibits 147: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Product/Service
Exhibits 148: Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd. - Key offerings
Exhibits 149: Solara Active Pharma Sciences Ltd. - Overview
Exhibits 150: Solara Active Pharma Sciences Ltd. - Product/Service
Exhibits 151: Solara Active Pharma Sciences Ltd. - Key offerings
Exhibits 152: Strides Pharma Science Ltd. - Overview
Exhibits 153: Strides Pharma Science Ltd. - Business segments
Exhibits 154: Strides Pharma Science Ltd. - Key offerings
Exhibits 155: Strides Pharma Science Ltd. - Segment focus
Exhibits 156: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 157: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 158: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 159: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 160: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 161: Inclusions checklist
Exhibits 162: Exclusions checklist
Exhibits 163: Currency conversion rates for US$
Exhibits 164: Research methodology
Exhibits 165: Validation techniques employed for market sizing
Exhibits 166: Information sources
Exhibits 167: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global ibuprofen API market: Arch Pharmalabs Ltd., Athos Chemicals Pvt. Ltd., Azelis SA, BASF SE, Chemino Pharma Ltd., Dr Reddys Laboratories Ltd., Granules India Ltd., HELM AG, IOL Chemicals and Pharmaceuticals Ltd., Mallinckrodt Plc, Octavius Pharma Pvt Ltd., Piramal Enterprises Ltd., Rochem International Inc., SI Group Inc., Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd., Solara Active Pharma Sciences Ltd., Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., Titan Lab Pvt Ltd., and Otto Brandes GmbH.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is paradigm shift in API manufacturing.'

According to the report, one of the major drivers for this market is the increasing geriatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

• Arch Pharmalabs Ltd.
• Athos Chemicals Pvt. Ltd.
• Azelis SA
• BASF SE
• Chemino Pharma Ltd.
• Dr Reddys Laboratories Ltd.
• Granules India Ltd.
• HELM AG
• IOL Chemicals and Pharmaceuticals Ltd.
• Mallinckrodt Plc
• Octavius Pharma Pvt Ltd.
• Piramal Enterprises Ltd.
• Rochem International Inc.
• SI Group Inc.
• Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd.
• Solara Active Pharma Sciences Ltd.
• Strides Pharma Science Ltd.
• Teva Pharmaceutical Industries Ltd.
• Titan Lab Pvt Ltd.
• Otto Brandes GmbH